163 related articles for article (PubMed ID: 16527473)
1. A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin.
Maestrelli F; Garcia-Fuentes M; Mura P; Alonso MJ
Eur J Pharm Biopharm; 2006 Jun; 63(2):79-86. PubMed ID: 16527473
[TBL] [Abstract][Full Text] [Related]
2. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system.
Krauland AH; Alonso MJ
Int J Pharm; 2007 Aug; 340(1-2):134-42. PubMed ID: 17459620
[TBL] [Abstract][Full Text] [Related]
3. The potential of glycol chitosan nanoparticles as carrier for low water soluble drugs.
Trapani A; Sitterberg J; Bakowsky U; Kissel T
Int J Pharm; 2009 Jun; 375(1-2):97-106. PubMed ID: 19481695
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
Chen F; Zhang ZR; Huang Y
Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144
[TBL] [Abstract][Full Text] [Related]
5. Mathematical modelling of the transport of hydroxypropyl-β-cyclodextrin inclusion complexes of ranitidine hydrochloride and furosemide loaded chitosan nanoparticles across a Caco-2 cell monolayer.
Sadighi A; Ostad SN; Rezayat SM; Foroutan M; Faramarzi MA; Dorkoosh FA
Int J Pharm; 2012 Jan; 422(1-2):479-88. PubMed ID: 22101294
[TBL] [Abstract][Full Text] [Related]
6. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
7. Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation.
Liu Z; Jiao Y; Liu F; Zhang Z
J Biomed Mater Res A; 2007 Dec; 83(3):806-12. PubMed ID: 17559117
[TBL] [Abstract][Full Text] [Related]
8. Novel hyaluronan-based nanocarriers for transmucosal delivery of macromolecules.
de la Fuente M; Seijo B; Alonso MJ
Macromol Biosci; 2008 May; 8(5):441-50. PubMed ID: 18236434
[TBL] [Abstract][Full Text] [Related]
9. Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir.
Ghera BB; Perret F; Chevalier Y; Parrot-Lopez H
Int J Pharm; 2009 Jun; 375(1-2):155-62. PubMed ID: 19481701
[TBL] [Abstract][Full Text] [Related]
10. Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins.
Grenha A; Remuñán-López C; Carvalho EL; Seijo B
Eur J Pharm Biopharm; 2008 May; 69(1):83-93. PubMed ID: 18166446
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
Amidi M; Romeijn SG; Borchard G; Junginger HE; Hennink WE; Jiskoot W
J Control Release; 2006 Mar; 111(1-2):107-16. PubMed ID: 16380189
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery.
Khalil SK; El-Feky GS; El-Banna ST; Khalil WA
Carbohydr Polym; 2012 Oct; 90(3):1244-53. PubMed ID: 22939337
[TBL] [Abstract][Full Text] [Related]
13. Sustained release of ATP encapsulated in chitosan oligosaccharide nanoparticles.
Du YZ; Ying XY; Wang L; Zhai Y; Yuan H; Yu RS; Hu FQ
Int J Pharm; 2010 Jun; 392(1-2):164-9. PubMed ID: 20362652
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives.
Bayat A; Larijani B; Ahmadian S; Junginger HE; Rafiee-Tehrani M
Nanomedicine; 2008 Jun; 4(2):115-20. PubMed ID: 18339584
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of new insulin containing polysaccharide nanoparticles.
Sarmento B; Ribeiro A; Veiga F; Ferreira D
Colloids Surf B Biointerfaces; 2006 Dec; 53(2):193-202. PubMed ID: 17049214
[TBL] [Abstract][Full Text] [Related]
16. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles.
Bravo-Osuna I; Schmitz T; Bernkop-Schnürch A; Vauthier C; Ponchel G
Int J Pharm; 2006 Jun; 316(1-2):170-5. PubMed ID: 16580797
[TBL] [Abstract][Full Text] [Related]
17. Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro.
Teijeiro-Osorio D; Remuñán-López C; Alonso MJ
Eur J Pharm Biopharm; 2009 Feb; 71(2):257-63. PubMed ID: 18955137
[TBL] [Abstract][Full Text] [Related]
18. Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules.
Goycoolea FM; Lollo G; Remuñán-López C; Quaglia F; Alonso MJ
Biomacromolecules; 2009 Jul; 10(7):1736-43. PubMed ID: 19545119
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrins and chitosan derivatives in sublingual delivery of low solubility peptides: A study using cyclosporin A, alpha-cyclodextrin and quaternary chitosan N-betainate.
Mannila J; Järvinen K; Holappa J; Matilainen L; Auriola S; Jarho P
Int J Pharm; 2009 Oct; 381(1):19-24. PubMed ID: 19632311
[TBL] [Abstract][Full Text] [Related]
20. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q
Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]